FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386072956> ?p ?o ?g. }

• W4386072956 endingPage "1397" @default.
• W4386072956 startingPage "1397" @default.
• W4386072956 abstract "Controlling avian influenza viruses (AIVs) is mainly based on culling of the infected bird flocks or via the implementation of inactivated vaccines in countries where AIVs are considered to be endemic. Over the last decade, several avian influenza virus subtypes, including highly pathogenic avian influenza (HPAI) H5N1 clade 2.2.1.2, H5N8 clade 2.3.4.4b and the recent H5N1 clade 2.3.4.4b, have been reported among poultry populations in Egypt. This demanded the utilization of a nationwide routine vaccination program in the poultry sector. Antigenic differences between available avian influenza vaccines and the currently circulating H5Nx strains were reported, calling for an updated vaccine for homogenous strains. In this study, three H5Nx vaccines were generated by utilizing the reverse genetic system: rgH5N1_2.3.4.4, rgH5N8_2.3.4.4 and rgH5N1_2.2.1.2. Further, the immunogenicity and the cross-reactivity of the generated inactivated vaccines were assessed in the chicken model against a panel of homologous and heterologous H5Nx HPAIVs. Interestingly, the rgH5N1_2.3.4.4 induced high immunogenicity in specific-pathogen-free (SPF) chicken and could efficiently protect immunized chickens against challenge infection with HPAIV H5N1_2.3.4.4, H5N8_2.3.4.4 and H5N1_2.2.1.2. In parallel, the rgH5N1_2.2.1.2 could partially protect SPF chickens against infection with HPAIV H5N1_2.3.4.4 and H5N8_2.3.4.4. Conversely, the raised antibodies to rgH5N1_2.3.4.4 could provide full protection against HPAIV H5N1_2.3.4.4 and HPAIV H5N8_2.3.4.4, and partial protection (60%) against HPAIV H5N1_2.2.1.2. Compared to rgH5N8_2.3.4.4 and rgH5N1_2.2.1.2 vaccines, chickens vaccinated with rgH5N1_2.3.4.4 showed lower viral shedding following challenge infection with the predefined HPAIVs. These data emphasize the superior immunogenicity and cross-protective efficacy of the rgH5N1_2.3.4.4 in comparison to rgH5N8_2.3.4.4 and rgH5N1_2.2.1.2." @default.
• W4386072956 created "2023-08-23" @default.
• W4386072956 creator A5001116543 @default.
• W4386072956 creator A5005044269 @default.
• W4386072956 creator A5019166946 @default.
• W4386072956 creator A5027999386 @default.
• W4386072956 creator A5032536815 @default.
• W4386072956 creator A5047894464 @default.
• W4386072956 creator A5048430604 @default.
• W4386072956 creator A5053133622 @default.
• W4386072956 creator A5055580344 @default.
• W4386072956 creator A5061184178 @default.
• W4386072956 creator A5085558806 @default.
• W4386072956 creator A5087116077 @default.
• W4386072956 date "2023-08-22" @default.
• W4386072956 modified "2023-10-17" @default.
• W4386072956 title "Immunogenicity and Cross-Protective Efficacy Induced by an Inactivated Recombinant Avian Influenza A/H5N1 (Clade 2.3.4.4b) Vaccine against Co-Circulating Influenza A/H5Nx Viruses" @default.
• W4386072956 cites W121869627 @default.
• W4386072956 cites W1965349138 @default.
• W4386072956 cites W1965540493 @default.
• W4386072956 cites W2010358813 @default.
• W4386072956 cites W2023052383 @default.
• W4386072956 cites W2048305874 @default.
• W4386072956 cites W2082014384 @default.
• W4386072956 cites W2085537532 @default.
• W4386072956 cites W2091976848 @default.
• W4386072956 cites W2110135196 @default.
• W4386072956 cites W2111647009 @default.
• W4386072956 cites W2160378127 @default.
• W4386072956 cites W2169259155 @default.
• W4386072956 cites W2261609884 @default.
• W4386072956 cites W2284810530 @default.
• W4386072956 cites W2297352394 @default.
• W4386072956 cites W2761313384 @default.
• W4386072956 cites W2789981064 @default.
• W4386072956 cites W2794043700 @default.
• W4386072956 cites W2889017150 @default.
• W4386072956 cites W3080165102 @default.
• W4386072956 cites W3087255345 @default.
• W4386072956 cites W3092588345 @default.
• W4386072956 cites W3109409758 @default.
• W4386072956 cites W3136123769 @default.
• W4386072956 cites W3194960798 @default.
• W4386072956 cites W3213215640 @default.
• W4386072956 cites W4200231192 @default.
• W4386072956 cites W4200570346 @default.
• W4386072956 cites W4243280074 @default.
• W4386072956 cites W4282838300 @default.
• W4386072956 cites W4291152247 @default.
• W4386072956 cites W4308204702 @default.
• W4386072956 cites W4313570229 @default.
• W4386072956 cites W4323313810 @default.
• W4386072956 cites W4328129260 @default.
• W4386072956 cites W4362721050 @default.
• W4386072956 cites W4376954872 @default.
• W4386072956 cites W4380841318 @default.
• W4386072956 cites W4385230043 @default.
• W4386072956 cites W4385486940 @default.
• W4386072956 doi "https://doi.org/10.3390/vaccines11091397" @default.
• W4386072956 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37766075" @default.
• W4386072956 hasPublicationYear "2023" @default.
• W4386072956 type Work @default.
• W4386072956 citedByCount "0" @default.
• W4386072956 crossrefType "journal-article" @default.
• W4386072956 hasAuthorship W4386072956A5001116543 @default.
• W4386072956 hasAuthorship W4386072956A5005044269 @default.
• W4386072956 hasAuthorship W4386072956A5019166946 @default.
• W4386072956 hasAuthorship W4386072956A5027999386 @default.
• W4386072956 hasAuthorship W4386072956A5032536815 @default.
• W4386072956 hasAuthorship W4386072956A5047894464 @default.
• W4386072956 hasAuthorship W4386072956A5048430604 @default.
• W4386072956 hasAuthorship W4386072956A5053133622 @default.
• W4386072956 hasAuthorship W4386072956A5055580344 @default.
• W4386072956 hasAuthorship W4386072956A5061184178 @default.
• W4386072956 hasAuthorship W4386072956A5085558806 @default.
• W4386072956 hasAuthorship W4386072956A5087116077 @default.
• W4386072956 hasBestOaLocation W43860729561 @default.
• W4386072956 hasConcept C104317684 @default.
• W4386072956 hasConcept C140793950 @default.
• W4386072956 hasConcept C147483822 @default.
• W4386072956 hasConcept C159047783 @default.
• W4386072956 hasConcept C194775826 @default.
• W4386072956 hasConcept C203014093 @default.
• W4386072956 hasConcept C22070199 @default.
• W4386072956 hasConcept C2522874641 @default.
• W4386072956 hasConcept C2776872762 @default.
• W4386072956 hasConcept C2777546802 @default.
• W4386072956 hasConcept C2780868878 @default.
• W4386072956 hasConcept C44465124 @default.
• W4386072956 hasConcept C519248777 @default.
• W4386072956 hasConcept C52991690 @default.
• W4386072956 hasConcept C54355233 @default.
• W4386072956 hasConcept C7842527 @default.
• W4386072956 hasConcept C86803240 @default.
• W4386072956 hasConcept C90132467 @default.
• W4386072956 hasConceptScore W4386072956C104317684 @default.
• W4386072956 hasConceptScore W4386072956C140793950 @default.
• W4386072956 hasConceptScore W4386072956C147483822 @default.

• next